HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jia He Selected Research

DMP 444

8/2011Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jia He Research Topics

Disease

84Neoplasms (Cancer)
04/2022 - 05/2002
28Hepatocellular Carcinoma (Hepatoma)
11/2021 - 05/2002
16Inflammation (Inflammations)
02/2022 - 05/2005
13Obesity
01/2022 - 01/2010
12Hypertension (High Blood Pressure)
01/2022 - 01/2010
10Cardiovascular Diseases (Cardiovascular Disease)
09/2022 - 01/2010
10Breast Neoplasms (Breast Cancer)
04/2022 - 01/2011
10Neoplasm Metastasis (Metastasis)
02/2022 - 09/2014
10Stroke (Strokes)
01/2022 - 01/2011
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2011
8Lung Neoplasms (Lung Cancer)
02/2022 - 01/2013
8Ischemic Stroke
01/2022 - 01/2013
8Infections
11/2021 - 01/2012
8Liver Neoplasms (Liver Cancer)
12/2020 - 03/2004
7Myocardial Infarction
09/2022 - 03/2010
7Hemorrhage
01/2022 - 01/2012
6Insulin Resistance
01/2022 - 11/2014
5Esophageal Squamous Cell Carcinoma
07/2022 - 03/2013
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2014
5Leiomyoma (Uterine Fibroids)
10/2021 - 12/2012
5Hypoxia (Hypoxemia)
01/2021 - 10/2014
5Carcinogenesis
01/2020 - 01/2017
5Drug-Related Side Effects and Adverse Reactions
12/2019 - 03/2008
4Acute Lung Injury
01/2022 - 01/2020
4Pulmonary Embolism
01/2022 - 08/2011
4Carcinoma (Carcinomatosis)
01/2022 - 01/2020
4COVID-19
01/2022 - 01/2020
4Coronary Disease (Coronary Heart Disease)
12/2021 - 03/2010
4Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2014
4Acute Kidney Injury (Acute Renal Failure)
01/2021 - 01/2019
4Osteoporosis
04/2020 - 05/2019
4Body Weight (Weight, Body)
10/2019 - 05/2011
4Dyslipidemias (Dyslipidemia)
01/2019 - 09/2015
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 02/2004
4Stomach Neoplasms (Stomach Cancer)
01/2019 - 01/2012
4Abdominal Obesity
12/2017 - 05/2010
4Overweight
02/2016 - 01/2015
3Pneumonia (Pneumonitis)
01/2022 - 01/2020
3Cardiomyopathies (Cardiomyopathy)
01/2022 - 09/2014
3Thrombosis (Thrombus)
01/2022 - 08/2011
3Foreign-Body Reaction
01/2022 - 02/2020
3Wounds and Injuries (Trauma)
01/2022 - 12/2021
3Burns
01/2022 - 11/2007
3Chronic Renal Insufficiency
12/2021 - 02/2014
3Fibrosis (Cirrhosis)
12/2021 - 05/2016
3Sepsis (Septicemia)
01/2021 - 01/2019

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
03/2022 - 02/2004
22CytokinesIBA
01/2022 - 07/2010
21Pharmaceutical PreparationsIBA
08/2022 - 07/2003
13Biological ProductsIBA
03/2022 - 11/2011
11Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2010
10LipidsIBA
01/2022 - 01/2012
9Long Noncoding RNAIBA
01/2022 - 01/2017
9MicroRNAs (MicroRNA)IBA
01/2022 - 03/2010
8CateninsIBA
09/2022 - 11/2015
8Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2012
7Messenger RNA (mRNA)IBA
01/2022 - 01/2011
7Therapeutic UsesIBA
01/2022 - 05/2005
7Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2017
6Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2010
6Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021 - 12/2015
6Interleukin-6 (Interleukin 6)IBA
07/2020 - 10/2012
6oxidized low density lipoproteinIBA
02/2016 - 12/2015
5InflammasomesIBA
01/2022 - 09/2012
5Immune Checkpoint InhibitorsIBA
12/2021 - 11/2019
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2021 - 02/2014
5HDL CholesterolIBA
12/2017 - 01/2010
5DNA (Deoxyribonucleic Acid)IBA
11/2014 - 02/2004
4EnzymesIBA
01/2022 - 04/2010
4ORALIT (ORS)IBA
01/2022 - 07/2011
4Small Interfering RNA (siRNA)IBA
01/2019 - 11/2014
4AntibodiesIBA
01/2019 - 01/2012
4Capsules (Microcapsules)IBA
03/2015 - 07/2003
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 11/2019
3Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2011
3Interleukin-27 (Interleukin 27)IBA
01/2022 - 01/2015
3AntigensIBA
01/2022 - 08/2012
3Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 01/2020
3Hematoxylin (Haematoxylon)IBA
01/2022 - 01/2020
3RNA (Ribonucleic Acid)IBA
01/2022 - 12/2018
3ChemokinesIBA
11/2021 - 01/2017
3Antihypertensive Agents (Antihypertensives)IBA
11/2021 - 02/2014
3CollagenIBA
10/2021 - 07/2009
3Insulin (Novolin)FDA Link
10/2021 - 09/2015
3PlatinumIBA
01/2021 - 01/2013
3Oxygen (Dioxygen)IBA
01/2021 - 01/2019
3CreatinineIBA
01/2021 - 04/2011
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021 - 05/2016

Therapy/Procedure

38Therapeutics
01/2022 - 07/2003
21Immunotherapy
01/2022 - 06/2010
12Drug Therapy (Chemotherapy)
01/2021 - 02/2004
9Length of Stay
12/2021 - 11/2017
5Radiotherapy
01/2021 - 10/2014
4Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2022 - 01/2020
4Injections
01/2020 - 03/2008
4Radiofrequency Ablation
09/2014 - 11/2002
3Aftercare (After-Treatment)
02/2022 - 05/2005
3Cell- and Tissue-Based Therapy (Cell Therapy)
01/2022 - 02/2015
3Chemoradiotherapy
01/2022 - 02/2015
3Prostatectomy (Retropubic Prostatectomy)
11/2020 - 03/2020